A: Tirzepatide is a strong option for patients who had an inadequate response to semaglutide (less than 10% body weight loss at maximum tolerated dose), those with prominent insulin resistance, and patients who require more aggressive weight reduction to manage obesity-related comorbidities
In the event of a medical emergency, such as chest pain that radiates to the arm or jaw, call 911 immediately
Weight loss head-to-head Retatrutide at 12mg produced approximately 24% body weight loss at 48 weeks
For maximum weight-loss and hepatic-fat research endpoints, retatrutide leads with 24.2% mean body-weight loss (Phase 2), driven by its unique triple GLP-1/GIP/glucagon receptor agonism
Some people exploring GLP-1 therapy for diabetes or weight management also consider surgical approaches
If you are taking a statin or other lipid-lowering medication, you have documented dyslipidemia by definition